URGN
Price
$19.21
Change
+$0.29 (+1.53%)
Updated
Aug 20, 03:41 PM (EDT)
Capitalization
875.32M
89 days until earnings call
VTGN
Price
$3.01
Change
-$0.16 (-5.05%)
Updated
Aug 20, 03:37 PM (EDT)
Capitalization
97.26M
Interact to see
Advertisement

URGN vs VTGN

Header iconURGN vs VTGN Comparison
Open Charts URGN vs VTGNBanner chart's image
UroGen Pharma
Price$19.21
Change+$0.29 (+1.53%)
Volume$35.43K
Capitalization875.32M
VistaGen Therapeutics
Price$3.01
Change-$0.16 (-5.05%)
Volume$700
Capitalization97.26M
URGN vs VTGN Comparison Chart in %
Loading...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corp (NASDAQ:INCY), Moderna (NASDAQ:MRNA), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Sarepta Therapeutics (NASDAQ:SRPT), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Nektar Therapeutics (NASDAQ:NKTR), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 1.83B. The market cap for tickers in the group ranges from 58 to 100.19B. VRTX holds the highest valuation in this group at 100.19B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -1%. For the same Industry, the average monthly price growth was 16%, and the average quarterly price growth was 22%. HIND experienced the highest price growth at 344%, while BMNDF experienced the biggest fall at -84%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -36%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was 24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 57
SMR Rating: 100
Profit Risk Rating: 95
Seasonality Score: -12 (-100 ... +100)

Market Cap

The average market capitalization across the group is 486.29M. The market cap for tickers in the group ranges from 97.26M to 875.32M. URGN holds the highest valuation in this group at 875.32M. The lowest valued company is VTGN at 97.26M.

High and low price notable news

The average weekly price growth across all stocks in the group was 5%. For the same group, the average monthly price growth was 24%, and the average quarterly price growth was 44%. VTGN experienced the highest price growth at 11%, while URGN experienced the biggest fall at -1%.

Volume

The average weekly volume growth across all stocks in the group was 99%. For the same stocks of the group, the average monthly volume growth was 35% and the average quarterly volume growth was 216%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 100
Price Growth Rating: 37
SMR Rating: 100
Profit Risk Rating: 100
Seasonality Score: -17 (-100 ... +100)
VS
URGN vs. VTGN commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is URGN is a Hold and VTGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 20, 2025
Stock price -- (URGN: $18.92 vs. VTGN: $3.17)
Brand notoriety: URGN and VTGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: URGN: 39% vs. VTGN: 131%
Market capitalization -- URGN: $875.32M vs. VTGN: $97.26M
URGN [@Biotechnology] is valued at $875.32M. VTGN’s [@Biotechnology] market capitalization is $97.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.19B to $0. The average market capitalization across the [@Biotechnology] industry is $1.83B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VTGN’s FA Score shows that 0 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • VTGN’s FA Score: 0 green, 5 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, VTGN is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

URGN’s TA Score shows that 3 TA indicator(s) are bullish while VTGN’s TA Score has 6 bullish TA indicator(s).

  • URGN’s TA Score: 3 bullish, 6 bearish.
  • VTGN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VTGN is a better buy in the short-term than URGN.

Price Growth

URGN (@Biotechnology) experienced а -1.46% price change this week, while VTGN (@Biotechnology) price change was +10.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.53%. For the same industry, the average monthly price growth was +15.57%, and the average quarterly price growth was +21.56%.

Reported Earning Dates

URGN is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (-0.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($875M) has a higher market cap than VTGN($97.3M). URGN YTD gains are higher at: 77.653 vs. VTGN (7.458). VTGN has higher annual earnings (EBITDA): -58.99M vs. URGN (-119.79M). URGN has more cash in the bank: 196M vs. VTGN (63.2M). VTGN has less debt than URGN: VTGN (2.36M) vs URGN (125M). URGN has higher revenues than VTGN: URGN (91.9M) vs VTGN (646K).
URGNVTGNURGN / VTGN
Capitalization875M97.3M899%
EBITDA-119.79M-58.99M203%
Gain YTD77.6537.4581,041%
P/E RatioN/AN/A-
Revenue91.9M646K14,226%
Total Cash196M63.2M310%
Total Debt125M2.36M5,306%
FUNDAMENTALS RATINGS
VTGN vs URGN: Fundamental Ratings
VTGN
URGN
OUTLOOK RATING
1..100
880
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4035
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VTGN's Valuation (48) in the Biotechnology industry is in the same range as URGN (71). This means that VTGN’s stock grew similarly to URGN’s over the last 12 months.

VTGN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as URGN (100). This means that VTGN’s stock grew similarly to URGN’s over the last 12 months.

VTGN's SMR Rating (100) in the Biotechnology industry is in the same range as URGN (100). This means that VTGN’s stock grew similarly to URGN’s over the last 12 months.

URGN's Price Growth Rating (35) in the Biotechnology industry is in the same range as VTGN (40). This means that URGN’s stock grew similarly to VTGN’s over the last 12 months.

URGN's P/E Growth Rating (100) in the Biotechnology industry is in the same range as VTGN (100). This means that URGN’s stock grew similarly to VTGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
URGNVTGN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
82%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDJX33.54N/A
N/A
MFS International New Discovery R4
BEQAX36.27N/A
N/A
American Century Equity Growth A
SVIFX9.41N/A
N/A
Virtus Ceredex Large-Cap Value Equity C
TDFCX8.34N/A
N/A
Transamerica Sustainable Equity Inc C
MSRFX17.78N/A
N/A
Morgan Stanley Inst Next Gen Em Mkts R6

URGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with AIM. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then AIM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
-2.47%
AIM - URGN
39%
Loosely correlated
+6.36%
CYYNF - URGN
38%
Loosely correlated
N/A
ATXS - URGN
35%
Loosely correlated
-7.08%
PHAT - URGN
34%
Loosely correlated
+2.77%
CVAC - URGN
34%
Loosely correlated
+0.18%
More

VTGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VTGN has been loosely correlated with COGT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VTGN jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTGN
1D Price
Change %
VTGN100%
-6.76%
COGT - VTGN
42%
Loosely correlated
-2.89%
CRSP - VTGN
41%
Loosely correlated
-5.96%
IMNM - VTGN
40%
Loosely correlated
-2.24%
SRRK - VTGN
40%
Loosely correlated
-4.44%
OCUL - VTGN
40%
Loosely correlated
-1.38%
More